Germany testing vaccine Volunteers Coronavirus Germany

German company BioNTech begins testing possible vaccine

Reading now: 961
www.livemint.com

BioNTech, which is working with U.S.-based Pfizer, said Wednesday that 12 participants of a clinical trial in Germany have received doses of the vaccine candidate BNT162 since April 23 German pharmaceutical company BioNTech says it has begun testing a potential vaccine for the new coronavirus on volunteers.

BioNTech, which is working with U.S.-based Pfizer, said Wednesday that 12 participants of a clinical trial in Germany have received doses of the vaccine candidate BNT162 since April 23.

Numerous pharmaceutical companies are racing to deliver a vaccine for the virus that has caused a pandemic and led to more than 215,000 deaths worldwide and sickened at least three million people.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA